Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Angelique Thornton
Research Nurse, Senior
Cancer Center Division
Map Page
Research Area
immunotherapy,
cancer therapy,
clinical trial,
pharmacology,
drug development,
ovarian cancer,
combination therapy,
dose escalation,
dose expansion,
platinum-resistant
Grants
(3)
A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec followed by Platinum-doublet Chemotherapy and Bevacizumab Compared with Platinum-doublet Chemotherapy and Bevacizumab in Women
Active
·
2023
·
$0 / $270.2K
·
External
clinical trials,
cancer treatment,
immunotherapy,
chemotherapy,
women's health
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study of Upifitamab Rilsodotin (XMT-1536) as Post-Platnum Maintenance Therapy for Participants with Recurrent, Platinum-Sensitive
2023
·
$0 / $217.6K
·
External
cancer therapy,
clinical trial,
pharmacology,
immunotherapy,
drug development
A Phase 1/2 Dose Escalation and Dose Expansion Study of ZNc3 in Combination with Niraparib in Subjects with Platinum Resistant Ovarian Cancer
2023
·
$0 / $18.4K
·
External
ovarian cancer,
combination therapy,
dose escalation,
dose expansion,
platinum-resistant
Collaborations
(7)
Setsuko Chambers
Mutual work: 3 Proposals﹒3 Grants
Collaboration Details
Janiel Cragun
Mutual work: 3 Grants﹒3 Proposals
Collaboration Details
Carolyn Lane
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Mitzi Miranda
Mutual work: 3 Proposals﹒3 Grants
Collaboration Details
Aradhana Kari
Mutual work: 3 Proposals﹒3 Grants
Collaboration Details
Page 1 of 2
Previous page
Next page
6+ Collaborators
$0 / $506.3K Funding